Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Germany

 

How occupational health captured the interest of private equity

Europe’s occupational health market is seeing growing interest from investors as employers across the continent become increasingly amenable to taking a proactive approach to supporting their employees’ health. The sector is beginning to see significant M&A and PE acquisitions.
September 20, 2024

Accenture to expand healthcare capabilities in Germany with acquisition of consus.health

Tech consultancy firm Accenture is going to expand its healthcare capabilities in Germany with the acquisition of leading German healthcare management consultancy, consus.health. The details of the acquisition, which is expected to complete subject to customary closing conditions, were not disclosed. Freiburg im Breisgau-based consus.health was founded in 2012 and has more than 600 healthcare […]
August 29, 2024

Interview: Dr. Guillermo Moreno-Sanz, Zerenia Clinic

Zerenia Clinic is a UK-based private healthcare provider specialising in treatments with cannabis-based medicinal products (CBMP). Last year it attained the UK’s first ever NHS reimbursement for cannabis flowers. In an interview with HBI, Dr. Guillermo Moreno-Sanz, Scientific Director at Zerenia’s parent company, Khiron Europe (a pharma company producing CBMPs), spoke about the growing opportunity in Europe’s medicinal cannabis space.
August 23, 2024

Challenges in German healthcare system present opportunities for tech-focused investors

Germany's healthcare system, known for its efficiency and quality, is currently facing substantial challenges, as highlighted by a recent McKinsey survey. The survey, conducted from November 2022 to January 2023, involved 201 physicians from various specialties and ages across Germany. While not representative, it included a diverse group of doctors.
August 16, 2024

Germany’s pharmaceutical company STADA expands its presence in MENA region

STADA, a European pharmaceutical company based in Germany, has acquired the FITO™ trademark from Leo Pharma, a multinational Danish pharmaceutical company, to expand its consumer healthcare presence in the Middle East and North Africa (MENA) region.  International law firm Bird & Bird has advised STADA Group on acquiring the FITO business from Leo Pharma in an asset deal.
August 16, 2024
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us